Proton Bio
company
About
Proton Bio is mainly engaged in gene and cell therapy CDMO service provider, focusing on the field of gene and cell therapy.
- 251 - 500
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥520M
- Industries
- Biopharma,Biotechnology,Medical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥520M
Proton Bio has raised a total of
¥520M
in funding over 2 rounds. Their latest funding was raised on
Aug 19, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 19, 2022 | Series B | ¥520M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Proton Bio is funded by 2 investors.
China Merchants Securities
and Huatai Health Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
China Merchants Securities
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
